comparemela.com

Latest Breaking News On - Subjective units - Page 2 : comparemela.com

First Participant Enrolled in Phase 3 Trial of Fasedienol for Social Anxiety Disorder

VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q3 2024 Earnings Call Transcript

Vistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate Update

Fasedienol PALISADE Phase 3 program for the acute treatment of social anxiety disorder remains on trackPALISADE-3 trial initiation anticipated in 1H 2024; PALISADE-4 trial initiation anticipated in 2H 2024SOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) $VTGN #mentalhealth Vistagen (Nasdaq: VTGN), a late clinical-stag.

United-states
Shawn-singh
Marka-mcpartland
Company-phase
Company-quarterly-report-on-form
International-number-toll
Women-health-indications
Exchange-commission
Chief-executive-officer
Nasal-spray
Acute-treatment
Social-anxiety-disorder

VistaGen: Positive Data Leads To Catalysts In 2024 And Beyond (NASDAQ:VTGN)

VistaGen: Positive Data Leads To Catalysts In 2024 And Beyond (NASDAQ:VTGN)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United-states
Japan
Japanese
Subjective-units
Distress-scale
Clinical-global-impressions-improvement
Vistagen-therapeutics
Social-anxiety
Social-anxiety-disorder
Liebowitz-social-anxiety-scale
New-drug-application

Vistagen Provides Corporate Update and Reports Fiscal 2024 Second Quarter Financial Results

Vistagen Provides Corporate Update and Reports Fiscal 2024 Second Quarter Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mexico
Japan
United-states
Shawn-singh
Nate-hitchings
Cindy-anderson
Jerrold-dotson
Mark-mcpartland
Exchange-commission
International-number-toll
Alnylam-pharmaceuticals
Drug-administration
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.